A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
Conditions
- Multiple Sclerosis (MS)
- Myasthenia Gravis (MG)
- Neuromyelitis Optica Spectrum Disorder
- Systemic Lupus Erythematosus
- Systemic Sclerosis
- Immune-Mediated Necrotizing Myopathy
Interventions
- BIOLOGICAL: CD20/BCMA-directed CAR-T cells Autologous 2nd generation
Sponsor
The Affiliated Hospital of Qingdao University
Collaborators